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Treatment of the extracranial carotid artery in tandem lesions 
during endovascular treatment of acute ischemic stroke:  
a systematic review and meta-analysis
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Abstract: Endovascular treatment (EVT) is the standard treatment for patients with an acute ischemic 
stroke due to occlusion of large vessel occlusion (LVO). In 20% of patients, concomitant extracranial 
internal carotid artery (EICA) lesion is present. These tandem lesions (TL) offer a technical challenge. The 
treatment strategy for the treatment of the ipsilateral EICA is unclear. The aim of this review is to compare 
two treatment strategies for TL during EVT: balloon angioplasty (BA) only and immediate carotid artery 
stenting (iCAS). A systematic review and meta-analysis was performed. Data for each included study was 
extracted. For comparative studies a meta-analysis was performed. Functional outcome was expressed with 
the modified Rankin scale and safety endpoints were mortality and symptomatic intracranial hemorrhage 
(sICH). A total of 72 full text articles evaluating treatment of TL during EVT were screened. Sixteen iCAS 
and five comparative studies were included for meta-analysis. 53% of patients undergoing iCAS during EVT 
had good functional outcome in comparison to 45% of patients who underwent only BA. Mortality was 
comparable at 16% for both groups. The incidences of sICH were 8% and 4% for iCAS and BA respectively. 
In the meta-analysis, iCAS was associated with good functional outcome, with no significant differences in 
mortality and sICH with compared to BA. This study shows that treatment with iCAS of a simultaneously 
ipsilateral EICA lesion during EVT is associated with a favorable functional outcome compared to BA only 
with no significant difference in mortality or sICH. No conclusion could be drawn about the intracranial 
or extracranial first approach due to scarce of data. More studies are needed to determine long-term 
neurological outcomes, the necessity of re-interventions and optimal technical approach (intracranial or 
extracranial first).
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Introduction
In 20–30% of patients with acute ischemic stroke (AIS) 
caused by an intracranial large vessel occlusion (LVO) there 
is a concomitant high-grade stenosis or occlusion of the 
ipsilateral extracranial internal carotid artery (EICA). For 
decades, these tandem lesions (TL) had a poor prognosis 
due to a poor response on intravenous thrombolysis (IVT) 
alone, with a favorable outcome of only 30% and mortality 
rates up to 50% (1,2). 
Recently, endovascular therapy (EVT), where the clot 
is mechanically extracted through endovascular access, 
has been proven effective and safe in patients with a 
LVO of the anterior circulation. EVT results in a higher 
recanalization rate and better functional outcomes than 
IVT alone and has been rapidly implemented in to national 
stroke guidelines and standard clinical care (3-5). For 
patients with a concomitant EICA lesion, EVT has also 
been shown to contribute to good functional outcome 
(6,7). In those patients with a significant EICA stenosis, a 
balloon angioplasty (BA) is performed in order gain access 
to the intracerebral vessels for thrombectomy. The BA does 
however not lead to a definitive treatment of the lesion as 
there is often a recoil or residual-stenosis of the EICA (8).
Current literature does not provide a clear answer on 
whether the EICA lesion should also be stented in the acute 
setting. Guidelines recommend carotid endarterectomy 
(CEA) within 2 weeks after the first event in order to 
prevent a second event, however this is based on trials 
comparing CEA and stenting in a different population 
of patients with a subacute TIA or non-disabling stroke 
(5,9-12). Acute patients may potentially benefit from 
early treatment as it further reduces the risk of recurrent 
stroke and the potential complication risks may be lower 
as endovascular access has already been obtained and the 
lesion has yet been passed with guidewires. The safety of 
immediate carotid artery stenting (iCAS) in the EVT group 
has not been fully elucidated. Since dual antiplatelet therapy 
(DAPT) is required after stenting, it may potentially lead to 
an increase in hemorrhagic complications in these patients 
with an acute stroke. Furthermore, it is unclear whether the 
EICA should be stented before or after recanalization of the 
occluded cerebral artery (13-17).
The aim of this review is to compare two treatment 
strategies, immediate CAS and BA, for tandem lesions 
during EVT and assess good functional outcome, efficacy 
and safety of external carotid artery treatment during EVT.
Methods
This systematic review was conducted in accordance to the 
Preferred Reporting Items for Systematic Review and Meta-
Analysis (PRISMA) statement and Cochrane guideline of 
systematic reviews of interventions (18,19).
Data sources
Databases of PubMed, Embase and Cochrane were 
searched till June 1st 2019 for eligible studies. Medical 
subject headings, terms and additional free entry terms for 
patient groups (patients with a tandem lesion, high-grade 
stenosis or occlusion, during acute ischemic stroke) and the 
treatment (BA, carotid artery stent) were used. The search 
strategy was formulated with the aid of a clinical librarian 
(Supplement file). The references of the selected papers 
were reviewed for the completion of the list of articles 
eligible for full text assessment. 
Study selection 
Two investigators (JH and ML) individually reviewed 
eligible titles and abstracts. Conflicts in inclusion were 
resolved through consensus. In case of disagreement a 
consensus was reached by consultation of a third reviewer 
(RB). Prespecified inclusion and exclusion criteria in our 
research protocol were used to select potentially eligible 
studies for full text analysis. Inclusion of a study followed 
if the study described the type of treatment of the EICA 
in TL during MT or delayed treatment after MT with 
separately reported outcomes. Prospective and retrospective 
observational studies, case series and randomized controlled 
trials were eligible for inclusion. Studies describing less 
than 10 patients were excluded from this review. The year 
of publication was no restriction on inclusion. Only full-text 
articles in English were included. 
Data extraction and quality assessment
One investigator (JH) extracted necessary information 
from the eligible articles. The data extracted was checked 
by sampling (RB, ML). Discrepancies were resolved by 
discussion between the investigators. If any of the main 
variables were missing or not reported separately, they were 
reported as missing data. 
Data on the year of publication and year of last inclusion, 
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number of included patients and type of procedure were 
extracted. Patient, procedural and outcome characteristics 
were recorded for all included articles. 
All studies were non-randomized trials. Therefore, the 
methodological quality of the included studies was evaluated 
by the ‘Methodological Index for Non-Randomized Studies’ 
(MINORS) (20). Quality was categorized as: very low (0 to 
6), low (7 to 10), fair (10 to 14) and good (>14).
Outcome measures
The primary goal of this review and meta-analysis was to 
estimate the incidence of good functional outcome at 90 days 
by means of modified Rankin Scale (mRS) score ≤2 (21). 
Secondary outcomes for this review were mortality at 
90 days, defined as a mRS score of 6 or otherwise noted 
in the articles 90 days after intervention, symptomatic 
intracerebral hemorrhage (sICH) defined as any extravascular 
blood in the cranium or brain associated with neurological 
deterioration by means of NIHSS of ≥4 points (22), 
successful reperfusion, defined as TICI 2b or higher (23), (in-
stent) re-stenosis or occlusion and cerebral hyperperfusion 
syndrome (CHS). We registered the preferable approach 
for recanalization (intracranial treatment versus extracranial 
treatment first respectively). One study defined sICH as any 
PH on following imaging (24) and one study only reported 
in-hospital mortality (25). 
In addition, odds ratio’s (ORs) were calculated to 
evaluate the association between type of intervention and 
the outcomes of favorable neurological outcome, sICH and 
mortality. 
Statistical analysis
A logit transformation was used to calculate an overall 
estimate from studies reporting single proportions. 
After back transformation, pooled incidences with their 
95% confidence intervals (95% CIs) were reported and 
illustrated in forest plots. Odds ratios with their 95% CIs 
were calculated and displayed for the comparative studies. 
All analyses were carried out using a random effects model.
To quantify heterogeneity, the Q-statistic, the between-
study variance [T2, and standard deviation (T)] and the ratio 
of true heterogeneity to total observed variation (I2) were 
computed. The between-study variance was estimated using 
the restricted maximum-likelihood estimator (REML). 
An I2 of >50% represented a large degree of inconsistency 
across the studies.
In addition to funnel plots, both the Egger’s test and 
Begg’s rank test were used to detect publication bias when 
the number of included studies was at least 20 (26). A P 
values of <0.05 were considered statistically significant. All 
statistical analyses were performed using R 3.6.1 software 
using the meta package (27,28).
Results
The search resulted in 391 records of which 319 were 
duplicates or irrelevant to the topic. After evaluation of 
the titles and abstracts, 72 articles were selected for full-
text assessment. Twenty-one studies met our inclusion 
criteria for this literature review (7,14-17,24,25,29-42). 
Most frequent reason for exclusion (n=37) of an article was 
that data was not presented separately on outcome for the 
different treatment options or insufficiently reported. The 
review process is summarized in detail in Figure 1. 
Fourteen of the 21 studies were retrospective cohort 
studies, six were comparative and one study was a 
prospective non-randomized observational study. The 
quality assessment of all 21 included studies is shown in 
Table 1. The methodological quality of the papers was low 
to fair. The MINORS score averaged 9.9 (9 to 11, SD 0.7) 
out of 16 for non-comparative studies and 16.8 (15 to 18, 
SD 1.1) out of 24 for comparative studies. 
Study characteristics
The included studies enrolled a total of 1,758 patients (mean 
sample size, 84; range, 10–482). Of all included patients, 
1,476 received iCAS (84%) during EVT and 149 underwent 
BA (8.4%). An extracranial first approach was favorable in 
15 out of the 21 included studies. In total 7.6% was not 
treated during EVT. Because of the unclear method of how 
they were treated during EVT, we performed no further 
analysis within this subgroup. 
Immediate carotid artery stent placement for extracranial 
lesions during EVT
Twenty-one of the 21 studies reported neurological 
outcome and safety for iCAS in patients undergoing EVT. 
Sixteen studies described only iCAS during EVT, of which 
only one study prospectively collected data. Table 1 shows 
the study characteristics in detail. 
The pooled incidences are depicted in Figure 2. Good 
neurological outcome was seen in 53% (95% CI, 46–59%). 
Hellegering et al. Treatment of carotid artery lesions during EVT
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The proportion of good neurological outcome varied 
largely across the studies (Q =116.52, d.f. =20, P<0.0001; 
T2=0.29; I2=82.8%). Mortality at 90 days was 16% (95% 
CI, 13–19%). Heterogeneity was low in these studies (Q 
=35.29, d.f. =20, P=0.02; T2=0.092; I2=43.3%). Mortality 
was mostly related to sICH (17,29,38,40) and pneumonia 
or sepsis (30,40). Age, duration of treatment and time to 
recanalization were independently associated for all-cause 
mortality (7). In addition, prior IVT and the severity of the 
stroke was also correlated to all-cause mortality (16).
The incidence of sICH was 8% (95% CI, 6–10%). No 
substantial heterogeneity was seen in the studies (Q =30.01, 
d.f. =20, P=0.07; T2=0.15; I2=33.4%). Successful cerebral 
reperfusion was reported in 19 studies and achieved in 79% 
(95% CI, 74–84%). There was a significant heterogeneity 
in this subgroup (Q =51.88, d.f. =18, P<0.0001; T2=0.25; 
I2=65.3%). In-stent occlusion or stenosis on follow up 
imaging was documented in ten studies with an absolute 
incidence of 7.6% (n=39). In total, 25 asymptomatic 
in-stent restenosis or occlusions, two symptomatic in-
stent occlusions after 24–48 hours and 12 acute in-stent 
occlusions were reported (17,24,29,31,32,34,35,40-42). 
Only two studies reported on CHS, with an incidence of 
2.4% (n=1) and 4.5% (n=1) (35,37). 
Visual inspection of the funnel plots shown in Figure 3 
indicate no presence of publication bias for favorable 
outcome, mortality and sICH. Using both the Egger’s test 
and Begg’s rank test, no statistically significant presence 
of publication bias was found (all P values >0.4). Due to 
missing data of two studies for successful reperfusion, there 
were not enough studies to perform a funnel plot for this 
outcome. 
BA for extracranial lesions during EVT
Five of the 21 studies reported neurological outcome 
and safety for iCAS in patients undergoing EVT. All 
studies were retrospectively comparative studies for iCAS 
(14-16,31,41). In all studies, the choice for BA was made 
by the discretion of the treating physicians, taking the 
access for distal treatment of the intracranial lesion into 
consideration. 
Figure 4 shows the pooled incidence of endpoints in 
the BA group. Favorable outcome was seen in 46% (95% 
CI, 36–55%). No substantial heterogeneity was seen in 
the studies (Q =4.89, d.f. =4, P=0.30; T2=0.04; I2=18.2%). 
Overall mortality at 90 days was 14.7%. Mortality at 
90 days was equal to the iCAS group with 16% (95% CI, 
10–23%). No significant heterogeneity was found (Q 
=3.71, d.f. = 4, P=0.45; T2<0.0001; I2=0.0%). Three cases of 
sICH, 4% (95% CI, 1–9%), were reported. No substantial 
heterogeneity was seen in the studies (Q =2.35, d.f. =4, 
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Figure 3 Funnel plots for publication bias on studies reporting immediate carotid stenting. (A) Favorable outcome (mRS); (B) mortality; (C) 
symptomatic intracranial hemorrhage.
Figure 2 Forest plots showing the overall pooled incidence for immediate carotid stenting. (A) Favorable outcome (mRS 0–2 at 90 days); (B) 
90 days mortality; (C) symptomatic intracranial hemorrhage; (D) successful reperfusion (TICI ≥2b).
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Figure 4 Forest plots showing the overall pooled incidence for BA. (A) Favorable outcome (mRS 0–2 at 90 days); (B) 90 days mortality; (C) 









P=0.67; T2=0.0; I2=0.0%). Reperfusion was only reported 
in four articles, with a successful reperfusion rate of 71% 
(95% CI, 37–91%) (15,31,36,41). Heterogeneity was low in 
these studies (Q =9.82, d.f. =2, P=0.01, T2=1.22; I2=79.6%). 
Asymptomatic post procedural EICA re-occlusion was 
described in 8% (n=8) on ultrasound (15,31,41). Nor acute 
nor symptomatic occlusions were reported. Of the two 
studies who reported CHS, no CHS occurred in the BA 
group.
iCAS versus BA alone during EVT
Five studies compared the iCAS to BA alone. All studies were 
nonrandomized observational studies. In the five included 
comparative studies for iCAS or BA, iCAS during EVT was 
associated with better functional outcome at 90 days than 
BA only (OR 1.99, 95% CI: 1.35–2.93%). Heterogeneity 
was low in these studies (Q =2.5, d.f. =4, P=0.64; T2=0.00; 
I2=0.0%). No association was found between iCAS and BA 
related to 90-day mortality (OR 1.27, 95% CI: 0.73–2.19) 
and sICH (OR 0.48, 95% CI: 0.16–1.45) (Figure 5A,B,C). 
There was no significant heterogeneity in these subgroups 
(Q =3.26, d.f. =4, P=0.52; T2=0.0; I2=0.0% and Q =2.00, 
d.f. =4, P=0.74; T2=0.0; I2=0.0% for mortality and sICH 
respectively). These findings follow the trend of the 
separately performed pooled incidence analysis.
Annals of Translational Medicine, Vol 8, No 19 October 2020 Page 9 of 13
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Extracranial treatment versus intracranial treatment first
In most studies approach considerations of the TL was 
reported, favoring extracranial approach first. Successful 
reperfusion in this group was seen in 84.7% with a 90-day 
good functional outcome of 47.2%. sICH was reported 
in 4.5% and 90-day mortality of 18.1% (7,17,24,30,32-
34,37,38,42).
In case of intracranial treatment first, successful 
reperfusion was seen in 80.3% and 90-day good functional 
outcome of 51.8% with 17.8% mortality rate and an 
incidence of 12.5% for sICH (15,32).
Only three studies reported outcomes of intracranial 
treatment first of which two discuss their motive for 
intracranial treatment first in more detail. Lockau et al. (32) 
found that the mean times from first puncture of the 
groin till reperfusion of intracranial occlusion and overall 
perfusion, including the ipsilateral EICA, were significantly 
shorter when the intracranial thrombectomy was performed 
prior to iCAS (43.1±30.8 vs. 110.8±43.0 min, P<0.001, 58.6± 
26.1 vs. 130.2±45.1 min, P<0.01 intracranial treatment vs. 
extracranial treatment first respectively). 
Another study (34) also compared both approaches. 
However, there was no significant difference in time 
from groin puncture till reperfusion [110 minutes (range, 
15–208 minutes) vs. 125 minutes (range, 45–212 minutes), 
P=0.42, intracranial treatment vs. extracranial treatment 
first respectively]. The authors also referred to an incidental 
finding with a potential benefit for extracranial approach 
first of spontaneous distal, e.g., intracranial, thrombus 
dissolution in 24% (n=4/17), without seeing this observation 
in the intracranial approach first.
Discussion
This systematic review and meta-analysis evaluate the safety 
and efficacy of treatment of EICA lesion in combination 
with an intracranial lesion during EVT by means of iCAS 
or BA. The current evaluation shows that despite the fact of 
having a tandem lesion, iCAS during EVT was associated 
Hellegering et al. Treatment of carotid artery lesions during EVT
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with a good 90-day functional outcome, without significant 
differences in mortality or bleeding complications in 
comparison to BA alone.
In 2016, the HERMES collective published the first 
meta-analysis on EVT for LVO. This study was focused 
on the intracranial LVO and confirmed the efficacy of 
EVT in this subgroup with a favorable functional outcome 
in 46.0% (3). The current review shows a comparable or 
better functional outcome at 90 days for EICA lesions 
treated with iCAS with similar incidence of mortality, with 
a slightly higher incidence of sICH. 
Bleeding complications like sICH due to DAPT are 
feared after treatment with stents in the acute phase, 
mainly because of the associated high morbidity and 
mortality afterwards. A few of the included studies showed 
a high incidence of sICH. A possible explanation for these 
high rates is the use of a strict and alternate high dosed 
antiplatelet regime. In up to 31% of a treated subgroup 
with Glycoprotein IIb/IIIA inhibitors (Abciximab, 
Eptifibatide respectively), sICH was reported (29,38). 
Treatment protocols of both studies were changed after 
these findings. Unfortunately, literature is ambiguous 
about the impact and effects of DAPT during CAS, nor is 
there consensus on a standardized antiplatelet regime for 
(immediate) CAS. As an example, none of the included 
studies in this review have applied the same antiplatelet 
protocol with a high heterogeneity among the studies. A 
meta-analysis in 2016 evaluated the evidence for DAPT 
after elective endovascular arterial procedures, with 
primary endpoint restenosis and stent thrombosis, with 
secondary endpoint bleeding complications (43). Most 
studies involved coronary literature, two studies involved 
CAS. They found no significant evidence for superiority 
for DAPT over monotherapy for neither restenosis nor for 
stent thrombosis. The two included carotid studies (44,45) 
both stopped prematurely because of the large differences 
in outcome between monotherapy and DAPT, in favor 
of DAPT with less neurological complications (stroke, 
transient ischemic attacks or intracerebral bleedings). 
However, none of latter studies looked at functional 
outcome nor mortality. 
Despite most studies did not report CHS, hyperperfusion 
after CAS is an infamous complication. Huibers et al. (46) 
investigated in their meta-analysis if CHS in clinically 
relevant in relation to procedural stroke rate following 
elective CAS. A pooled estimate for CHS of 3.5% 
was found, not associated with the type of anesthesia. 
Approximately 8% of CHS occurred after hospital 
discharge. However, the authors expect an underreporting 
due to a majority of the studies only report in hospital 
outcomes. 
Little is known about the long-term outcomes for TL 
treated with EVT. Ten included studies reported on acute 
stent occlusions and in-stent stenosis during follow up. 
Only one study documented the need for delayed treatment 
in both groups (15). In 22 cases of BA, delayed carotid 
revascularization was required by form of delayed iCAS 
(n=1) or carotid endarterectomy (CEA) (n=7). No additional 
treatment after iCAS were reported in this cohort. 
Long-term results of the EVA-3S, CREST and ICSS 
suggest a benefit-risk balance in favor of CEA over CAS 
on short term results after treatment. This difference 
is mainly driven by a lower risk of AIS during the 
intervention. Both techniques were associated with similar 
long-term risks of recurrent mainly non-disabling stroke, 
myocardial infarction and death up to 10 years after 
intervention (10-12). In case of EVT in the presence of a 
tandem lesion, a larger chance on disrupting the plaque 
and creating micro-emboli stroke due to passing of the 
carotid lesion is inherent to the executed EVT. Earlier 
drawn conclusions may therefore not be applicable for 
patient with TL undergoing EVT. However, insufficient 
data is available to make any statements on long-term 
results in this specific population.
Several included studies described predictors for 
good functional outcome. A TICI score of 3 and early 
neurological improvement are factors for a favorable 
outcome at 90 days (35). Other predictors of good 
functional outcome months are age (7,15,16,34,41), low 
NIHSS score at baseline (14,16) and procedure time to 
recanalization (7,15,41). An additional hour between arrival 
at the emergency department and puncture of the femoral 
artery was associated with a 22% reduction of TICI 2b/3 
reperfusion (47). In addition, in procedures ranging from 
20 to 60 min the functional outcome was good in 79% of 
patients (41). In procedures lasting more than 60min, only 
50% of the patients had a mRS 0–2 at long-term follow-
up. According to the adagium “time is brain”, a fast passage 
of the EICA and intracranial recanalization may further 
improve functional outcomes. It is possible to conclude that 
an intracranial first approach may be beneficial (48). 
This review holds some inherent limitations. Firstly, 
the quality of this systematic review and meta-analysis 
is directly related to the quality of the predominantly 
uncontrolled studies included. All but one study were 
retrospective series and therefore subjected to a marked 
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risk of selection bias. Most studies did not meet an 
adequate score on the MINORS tool. None of the studies 
prospectively randomized their study size nor was there 
mention of an unbiased assessment of the study endpoints. 
Secondly, there is a considerable heterogeneity among the 
studies due to different treatment plans, different primary 
outcomes and different antiplatelet regimes. As already 
discussed earlier on, the difference in antiplatelet regime 
may affect the neurological outcomes and complication 
rates. Thirdly, most studies depicted poorly the type of 
lesions found during EVT in the ipsilateral EICA. These 
different presentations may require different approaches 
with possible effect on outcome. Fourthly, only ten studies 
noted the presence of potential in-stent stenosis and re-
occlusions of the EICA after treatment. It is not sufficiently 
clear what the implications are on 90-day good functional 
outcome nor mortality nor the long-term outcome with 
BA of iCAS. Lastly, hemorrhagic complications were 
reported variously in the included studies. Several studies 
also reported parenchymal hemorrhages (subdivided or as 
one), asymptomatic ICH or even by any hemorrhage. Due 
to the lacking synchronicity of definitions, it is possible that 
an underestimation of relevant bleeding complications is 
represented in this review.
Conclusions
In conclusion, this systematic review shows that treatment 
with iCAS of a simultaneously ipsilateral EICA lesion 
during EVT is associated with a favorable functional 
outcome at 90 days compared to BA only with no significant 
increase in mortality or sICH. No conclusion could be 
drawn about the intracranial or extracranial first approach 
due to scarce of data. More studies are needed to determine 
long-term neurological outcomes, the necessity of re-
interventions and optimal technical approach (intracranial 
or extracranial first). Prospective randomized control trials 
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